Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.
In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.
Business & Industry
- Pfizer and Lilly announce top-line results from long-term Phase 3 study of tanezumab in patients with osteoarthritis
- Roche reports a strong start in 2019 and raises the outlook for the full-year
- World Hemophilia Day: Sanofi Genzyme donation impacts patients across the globe
- Independent large real-world study comparing NOACs in AF-patients
- EVENITY™ (romosozumab-aqqg) now available in the United States for the treatment of osteoporosis in postmenopausal women at high risk for fracture
Research & Development
- Chemotherapy or not?
- Personalizing precision medicine with combination therapies improves outcomes in cancer
- Cannabidiol could help deliver medications to the brain
- High-dose vitamin D shows benefit in patients with advanced colorectal cancer
- One-third of cancer patients use complementary and alternative medicine
- Immune cells fighting blood cancer visualized for the first time
- Compound that kills drug-resistant fungi is isolated from ant microbiota
Conferences & Events
- SMi's 9th Annual Conference: Biobanking 2019
- Last call for registrations to Pre-Filled Syringes East Coast conference
- Exclusive speaker interview with SCHOTT Pharmaceutical Systems released for Pre-Filled Syringes East Coast 2019
- Lyophilisation Conference 2019
- Pre-Filled Syringes West Coast conference 2019
- eyeforpharma Barcelona Conference, Expo & Awards 2019
- SMi presents the 2nd Annual Conference: Injectable Drug Delivery 2019
Regulatory Affairs
- FDA permits marketing of first medical device for treatment of ADHD
- FDA approves first generic naloxone nasal spray to treat opioid overdose
- FDA approves first targeted therapy for metastatic bladder cancer
- FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture
- FDA expands approved use of metastatic breast cancer treatment to include male patients